Product news from the 09/12/06 News Brief
Barr Pharmaceuticals launched a generic version of its extended-cycle oral contraceptive Seasonale under the tradename Jolessa. The company launched this generic version of Seasonale following the final FDA approval of Watson Laboratories’ Abbreviated New Drug Application (ANDA) for a generic version of Seasonale. Watson received approval following the expiration of the Barr’s three-year new product exclusivity on Sept. 5, 2006.
King Pharmaceuticals entered into an agreement with Ligand Pharmaceuticals to acquire rights to Avinza (morphine sulfate extended release). Avinza is an extended-release formulation of morphine and is indicated as a once-daily treatment for moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an extended period of time.